Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Colorado, Denver

About this trial

The goal of the proposed study is to understand the reasons for the variability in aerobic exercise (AE) training benefits on the vasculature in middle-age and older (MA/O) adults, including differences between men and women. To achieve this goal, a mechanistic randomized controlled (RCT) will be conducted, in which adults are randomized to 12-weeks intervention of AE or no-exercise Control. Our overall hypothesis is that the exercise response variation in vascular benefits is related to age and sex differences in the biological changes underlying vascular aging and/or the molecular transducers (i.e., circulating molecules) that communicate and coordinate the effects of AE on the vasculature in the periphery and brain. Because this is a mechanistic trial, the overall goal is not a single health-related outcome. Rather, the goal is to advance our understanding of the molecular signals and pathways underlying the systemic and local effects of AE on vascular health that may explain the variability in AE responses with age and sex. This knowledge will allow for the development of personalized age- and sex-specific AE recommendations, and/or provide insights into molecular targets that can be manipulated to enhance and/or mimic exercise in non-responders or in persons unable to exercise.

Eligibility criteria

Qualifiers

Ability to provide consent;

Man or woman >= 18 years;

Willing to be randomized to an exercise or control intervention;

No orthopedic limitations that would prevent the volunteer from performing treadmill or cycling exercise;

Disqualifiers

Contraindications to aerobic exercise;

Diabetic or fasted glucose >126 mg/dL;

Resting blood pressure >= 140/90 mmHg;

Current or past history of cancer other than skin cancer;

Trial design

Treatments tested in this trial

  • Aerobic Exercise Training

Treatment groups

242 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

National Institute on Aging (NIA)

Collaborator